StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) stock

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$12.85−0.07 (-0.54%)

Close on Nov 17, 2026Market cap $171.97MP/E –Yield –

Anika Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Anika Therapeutics's gross margin for the twelve months ending Jun 30, 2026 was 62.2%. For fiscal 2025 it was 56.6%, against 63.4% the year before. The highest annual figure on record is 80.2% in fiscal 2014.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202556.6%−6.8
FY2024Dec 31, 202463.4%−4.9
FY2023Dec 31, 202368.3%+4.0
FY2022Dec 31, 202264.3%+8.2
FY2021Dec 31, 202156.1%+3.2
FY2020Dec 31, 202052.9%−22.0
FY2019Dec 31, 201974.9%+4.6
FY2018Dec 31, 201870.4%−5.5
FY2017Dec 31, 201775.9%−0.9
FY2016Dec 31, 201676.8%−0.6
FY2015Dec 31, 201577.4%−2.8
FY2014Dec 31, 201480.2%+10.5
FY2013Dec 31, 201369.7%+10.3
FY2012Dec 31, 201259.4%+0.7
FY2011Dec 31, 201158.7%+1.5
FY2010Dec 31, 201057.1%−8.8
FY2009Dec 31, 200965.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202665.1%+14.2
Q1 FY2026Mar 31, 202664.2%+8.1
Q4 FY2025Dec 31, 202562.6%+6.7
Q3 FY2025Sep 30, 202556.0%−9.6
Q2 FY2025Jun 30, 202550.9%−15.8
Q1 FY2025Mar 31, 202556.1%−9.3
Q4 FY2024Dec 31, 202456.0%+42.5
Q3 FY2024Sep 30, 202465.7%+5.5
Q2 FY2024Jun 30, 202466.7%+1.3
Q1 FY2024Mar 31, 202465.4%+5.1
Q4 FY2023Dec 31, 202313.4%+3.9
Q3 FY2023Sep 30, 202360.2%+3.6
Q2 FY2023Jun 30, 202365.4%+2.7
Q1 FY2023Mar 31, 202360.2%+0.8
Q4 FY2022Dec 31, 20229.5%−41.1
Q3 FY2022Sep 30, 202256.6%−1.7
Q2 FY2022Jun 30, 202262.7%+8.1
Q1 FY2022Mar 31, 202259.4%−1.7
Q4 FY2021Dec 31, 202150.6%−0.6
Q3 FY2021Sep 30, 202158.2%+3.5
Q2 FY2021Jun 30, 202154.6%+9.8
Q1 FY2021Mar 31, 202161.2%+1.3
Q4 FY2020Dec 31, 202051.2%−19.7
Q3 FY2020Sep 30, 202054.7%−25.2
Q2 FY2020Jun 30, 202044.8%−32.7
Q1 FY2020Mar 31, 202059.9%−10.5
Q4 FY2019Dec 31, 201970.9%−3.1
Q3 FY2019Sep 30, 201980.0%+10.9
Q2 FY2019Jun 30, 201977.5%+4.2
Q1 FY2019Mar 31, 201970.4%+7.3
Q4 FY2018Dec 31, 201874.0%+5.4
Q3 FY2018Sep 30, 201869.1%−7.9
Q2 FY2018Jun 30, 201873.3%+7.5
Q1 FY2018Mar 31, 201863.1%−10.9
Q4 FY2017Dec 31, 201768.6%−3.6
Q3 FY2017Sep 30, 201777.0%−3.6
Q2 FY2017Jun 30, 201765.8%–
Q1 FY2017Mar 31, 201774.0%–
Q4 FY2016Dec 31, 201672.3%–
Q3 FY2016Sep 30, 201680.6%–

More Anika Therapeutics figures

See a number that looks wrong?